Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 70518-3273

5 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 70518-3273). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Atorvastatin Calcium 40 mg film-coated tablets packaging label shows a quantity of 30 tablets. The label includes the NDC number 70518-3273-00 and states it is repackaged by RemedyRepack Inc. Directions for use advise seeing the package insert, and storage instructions specify 20-25°C with permitted excursions. Manufacturer is Novadoz Pharmaceuticals LLC, Piscataway, NJ.*
FDA Label Image

Figure-01 (Atorvastatin Figure 01)

Figure-01 (Atorvastatin Figure 01)
A line graph comparing cumulative incidence percentages over time in years for Atorvastatin versus placebo. The graph plots two curves, with Atorvastatin showing lower cumulative incidence than placebo. A hazard ratio (HR) of 0.64 with a confidence interval and a p-value is noted on the graph.*
FDA Label Image

Figure-02 (Atorvastatin Figure 02)

Figure-02 (Atorvastatin Figure 02)
A line chart showing cumulative hazard percentage over time to first primary endpoint through four years of follow-up. The chart compares placebo (dashed line) and atorvastatin (solid line) groups, indicating lower cumulative hazard in the atorvastatin group throughout the period, with a hazard ratio of 0.63 (0.48-0.83) and p=0.001.*
FDA Label Image

Figure-03 (Atorvastatin Figure 03)

Figure-03 (Atorvastatin Figure 03)
A line graph showing the percentage of subjects experiencing an event over time up to 5 years. Two lines compare Atorvastatin 10 mg (dashed line) and Atorvastatin 80 mg (solid line) for time to first major cardiovascular endpoint, with the 80 mg group showing a lower event rate. The graph includes a hazard ratio (HR 0.78) with a confidence interval (0.69-0.89) and a p-value of 0.0002.*
FDA Label Image

Structure (Atorvastatin Structure)

Structure (Atorvastatin Structure)
Chemical structure of Atorvastatin calcium, showing its molecular framework with calcium ion complex and associated water molecules as depicted in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.